CD209/DC-SIGN rHu IgG1k mAb (Ref: INSERM patent)
Application
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Reactivity
Human
Target
| Target Name | DC-SIGN / CD209 |
| Target Uniprot | Q9NNX6 |
Overview
| Catalog# | BIO0147SM |
| Product Name | Anti-human DC-SIGN / CD209 (INSERM patent Anti-DC-SIGN Biosimilar) |
Specifications
| Conjugation | None |
| Formulation | 100 mM Pro-Ac 20mM Arg pH 5.0 |
| Storage | For long term storage, the produce should be stored at -20℃ or lower. |
| Reconstitution | Dissolve with sterile ddH2O |
| Concentration | Lot Dependent |
| Isotype | Human IgG1 |
| Calculated M.W. | 150 kDa |
| Endotoxin | <0.001 EU/ug |
| Expression System | CHO |
| Purification | Protein A |
Frequently asked questions
Which applications is CD209/DC-SIGN rHu IgG1k mAb (Ref: INSERM patent) (BIO0147SM) validated for, and at what dilution?
BIO0147SM is validated for In Vivo Research.